Press Releases

NTRR To Begin Clinical Trials Of Pure Plus This Week

Stock quotes in this article:NTRR 

Neutra Corp. (OTCBB: NTRR), an emerging nutraceuticals provider, expects to begin clinical trials of its eagerly anticipated new all-natural weight-loss supplement as early as this week when the company’s first batch of Pure Plus arrives from the manufacturer.

NTRR is currently in the midst of recruiting and qualifying suitable volunteers in order to begin testing as soon as the supplements are delivered. The initial test batch as well as each subsequent shipment of Pure Plus is first sent from the manufacturer to a laboratory for a highly specialized Bio-energy infusion that increases the potency of the ingredients, before the supplements’ final delivery to the company.

Beginning clinical trials on the all-natural fat-burner is an exciting, major step forward for the company. Pure Plus  will be the first in a product line of superior, all-natural supplements that Neutra Corp. is working to bring to retail shelves as quickly as possible. The breakthrough Bio-energy infusion proven to significantly enhance the supplement’s performance will be the hallmark that sets Pure Plus apart from its competitors.

NTRR expects to announce the results of the trial testing within 30 days of completion.

Neutra Corp. is developing Pure Plus and other new products to compete in the fast-growing nutraceuticals industry alongside Herbalife Ltd. (NYSE: HLF), Nature's Sunshine Prod. (NASDAQ: NATR), Nutraceutical International Corp. (NASDAQ: NUTR) and Schiff Nutrition International Inc. (NYSE: WNI).

For more information on NTRR’s nutraceuticals initiative, please visit www.neutracorp.com/investors.

Follow NTRR on Twitter at  www.twitter.com/neutracorp.

About Neutra Corp.

Neutra Corp.  ( www.neutracorp.com) is a healthy lifestyle company that specializes in the development and marketing of nutritional supplements, nutrient boosters, herbal remedies and other natural wellness solutions. The company is currently working to produce a full range of products to address every component of a healthy lifestyle, including muscle building, weight loss and general wellness through a daily nutrition regimen. For investing information and performance data, please visit  www.neutracorp.com/investors.

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of future success. This news release speaks as of the date first set forth above and the company assumes no responsibility to update the information included herein for events occurring after the date hereof.

TheStreet Premium Services

Jim Cramer
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
OptionsProfits
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Real Money
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
Dow Jones S&P 500 NASDAQ 10-Year Note
12,454.83 1,317.82 2,837.53 17.45
Oil *
107.26
DOWN
74.92
DOWN
2.86
DOWN
1.85
DOWN
0.14
10 Yr
1.74%
SPDR Gold
152.68
-0.60%
-0.22%
-0.07%
-0.80%
Data delayed 20 minutes

Top Stories and Tools

Articles From

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy.
Podcasts

Connect with TheStreet